Neuroprotective Effects of Marine Algae

doi:10.3390/md9050803

This article is

freely available
re-usable

Mar. Drugs 2011, 9(5), 803-818; doi:10.3390/md9050803

Review

Neuroprotective Effects of Marine Algae

Ratih Pangestuti¹ and Se-Kwon Kim^1,2,*

¹ Marine Biochemistry Laboratory, Department of Chemistry, Pukyong National University, Busan 608–737, Korea ² Marine Bioprocess Research Center, Pukyong National University, Busan 608–737, Korea

* Author to whom correspondence should be addressed.

Received: 25 February 2011; in revised form: 12 April 2011 / Accepted: 28 April 2011 / Published: 10 May 2011

Download PDF Full-Text [242 KB, uploaded 10 May 2011 14:55 CEST]

Abstract: The marine environment is known as a rich source of chemical structures with numerous beneficial health effects. Among marine organisms, marine algae have been identified as an under-exploited plant resource, although they have long been recognized as valuable sources of structurally diverse bioactive compounds. Presently, several lines of studies have provided insight into biological activities and neuroprotective effects of marine algae including antioxidant, anti-neuroinflammatory, cholinesterase inhibitory activity and the inhibition of neuronal death. Hence, marine algae have great potential to be used for neuroprotection as part of pharmaceuticals, nutraceuticals and functional foods. This contribution presents an overview of marine algal neuroprotective effects and their potential application in neuroprotection.

Keywords: marine algae; neuroprotective; neuroprotection

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Pangestuti, R.; Kim, S.-K. Neuroprotective Effects of Marine Algae. Mar. Drugs 2011, 9, 803-818.

AMA Style

Pangestuti R, Kim S-K. Neuroprotective Effects of Marine Algae. Marine Drugs. 2011; 9(5):803-818.

Chicago/Turabian Style

Pangestuti, Ratih; Kim, Se-Kwon. 2011. "Neuroprotective Effects of Marine Algae." Mar. Drugs 9, no. 5: 803-818.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert